{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:25:33Z","timestamp":1790735133472,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"crossref","award":["NV18-02-00027"],"award-info":[{"award-number":["NV18-02-00027"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Patients with pulmonary hypertension (PH) frequently suffer from supraventricular tachycardias (SVT). The main purpose of our study was to identify the cumulative incidence of SVT in patients with different etiologies of PH. The secondary objective was to analyse the clinical impact of SVT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively studied the prevalence of SVT and the clinical outcome in 755 patients (41% males; 60 \u00b1 15 years; mean follow-up 3.8 \u00b1 2.8 years) with PH of different etiologies. The prevalence of SVT was analysed separately in isolated pre-capillary PH (Ipc-PH) and in patients with combined post- and pre-capillary PH (Cpc-PH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of SVT in the Ipc-PH group (n = 641) was 25% (n = 162). The most prevalent arrhythmias were atrial fibrillation followed by a typical atrial flutter (17% and 4.4% of all Icp-PH patients). An excessive prevalence of SVT was found in patients with pulmonary arterial hypertension associated with congenital heart disease (35%, p = 0.01). Out of the overall study population, Cpc-PH was present in 114 (15%) patients. Patients with Cpc-PH manifested a higher prevalence of SVT than subjects with Ipc-PH (58; 51% vs. 162; 25%; p &lt;0.0001) and were more likely to have persistent or permanent atrial fibrillation (38; 29% vs. 61; 10%; p &lt;0.0001). Parameters significantly associated with mortality in a multivariate analysis included age, male gender, functional exercise capacity and right atrial diameter (p &lt; 0.05). Neither diagnosis of SVT nor type of arrhythmia predicted mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The study detected a significant prevalence of SVT in the population of PH of different origins. Different spectrum and prevalence of arrhythmia might be expected in different etiologies of PH. Patients with an elevated post-capillary pressure showed a higher arrhythmia prevalence, predominantly due to an excessive number of atrial fibrillations. The diagnosis of SVT was not associated with mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0245752","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T14:37:52Z","timestamp":1611153472000},"page":"e0245752","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension"],"prefix":"10.1371","volume":"16","author":[{"given":"Zdenka","family":"Fingrova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ambroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Jansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kuchar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8432-4069","authenticated-orcid":true,"given":"Jaroslav","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kunstyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aschermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3372-7850","authenticated-orcid":true,"given":"Ales","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-0344","authenticated-orcid":true,"given":"Stepan","family":"Havranek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"1","key":"pone.0245752.ref001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)","volume":"37","author":"N Galie","year":"2016","journal-title":"Eur Heart J"},{"issue":"12","key":"pone.0245752.ref002","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"G Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"pone.0245752.ref003","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","article-title":"Frequency of Supraventricular Arrhythmias in Patients With Idiopathic Pulmonary Arterial Hypertension","volume":"114","author":"L Wen","year":"2014","journal-title":"Am J Cardiol"},{"issue":"3","key":"pone.0245752.ref004","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018790316","article-title":"Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension","volume":"8","author":"B Smith","year":"2018","journal-title":"Pulm Circ"},{"issue":"5","key":"pone.0245752.ref005","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"KM Olsson","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0245752.ref006","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2010.09.065","article-title":"Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension","volume":"146","author":"MJ Ruiz-Cano","year":"2011","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0245752.ref007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension","volume":"153","author":"J Tongers","year":"2007","journal-title":"Am Heart J"},{"issue":"1","key":"pone.0245752.ref008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12872-019-1142-z","article-title":"The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension","volume":"19","author":"Z Fingrova","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"12","key":"pone.0245752.ref009","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1053\/euhj.1998.1046","article-title":"Eisenmenger syndrome. Factors relating to deterioration and death","volume":"19","author":"L Daliento","year":"1998","journal-title":"Eur Heart J"},{"issue":"Suppl F","key":"pone.0245752.ref010","doi-asserted-by":"crossref","first-page":"F30","DOI":"10.1093\/eurheartj\/suaa096","article-title":"Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy","volume":"22","author":"S Havranek","year":"2020","journal-title":"Eur Heart J Suppl"},{"issue":"3","key":"pone.0245752.ref011","doi-asserted-by":"crossref","first-page":"e33902","DOI":"10.1371\/journal.pone.0033902","article-title":"Clinical impact of atrial fibrillation in patients with pulmonary hypertension","volume":"7","author":"D Rottlaender","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"pone.0245752.ref012","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.amjcard.2015.09.039","article-title":"Supraventricular Arrhythmias in Patients With Pulmonary Arterial Hypertension","volume":"116","author":"M Cannillo","year":"2015","journal-title":"Am J Cardiol"},{"issue":"24","key":"pone.0245752.ref013","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"N Galie","year":"2004","journal-title":"Eur Heart J"},{"issue":"20","key":"pone.0245752.ref014","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)","volume":"30","author":"N Galie","year":"2009","journal-title":"Eur Heart J"},{"issue":"4","key":"pone.0245752.ref015","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.hrthm.2015.09.019","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"13","author":"RL Page","year":"2016","journal-title":"Heart Rhythm"},{"issue":"16","key":"pone.0245752.ref016","first-page":"1979","article-title":"ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)","volume":"27","author":"V Fuster","year":"2006","journal-title":"Eur Heart J"},{"issue":"19","key":"pone.0245752.ref017","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"European Heart Rhythm A","year":"2010","journal-title":"Eur Heart J"},{"issue":"12","key":"pone.0245752.ref018","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"GG Pietra","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"pone.0245752.ref019","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1540-8167.2011.02255.x","article-title":"Atrial Electrical and Structural Remodeling Associated with Longstanding Pulmonary Hypertension and Right Ventricular Hypertrophy in Humans","volume":"23","author":"C Medi","year":"2012","journal-title":"J Cardiovasc Electr"},{"issue":"6","key":"pone.0245752.ref020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00408-003-1034-x","article-title":"Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension","volume":"181","author":"AF Folino","year":"2003","journal-title":"Lung"},{"issue":"5","key":"pone.0245752.ref021","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2215\/CJN.01960408","article-title":"Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure?","volume":"3","author":"RW Schrier","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"pone.0245752.ref022","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jacc.2016.05.047","article-title":"Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum","volume":"68","author":"CF Opitz","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pone.0245752.ref023","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","author":"BA Borlaug","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"1","key":"pone.0245752.ref024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.chest.2016.08.1439","article-title":"Clinical Relevance of Fluid Challenge in Patients Evaluated for Pulmonary Hypertension","volume":"151","author":"M D'Alto","year":"2017","journal-title":"Chest"},{"issue":"9","key":"pone.0245752.ref025","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2014.05.007","article-title":"Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation","volume":"13","author":"PE Lazzerini","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"pone.0245752.ref026","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCEP.110.960435","article-title":"Catheter Ablation of Atrial Fibrillation in Patients With Chronic Lung Disease","volume":"4","author":"SY Roh","year":"2011","journal-title":"Circ-Arrhythmia Elec"},{"issue":"15","key":"pone.0245752.ref027","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/euhj.1999.2107","article-title":"Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure","volume":"21","author":"HJ Crijns","year":"2000","journal-title":"Eur Heart J"},{"issue":"6a","key":"pone.0245752.ref028","doi-asserted-by":"crossref","first-page":"2d","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrilation in heart failure: Epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"WH Maisel","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1","key":"pone.0245752.ref029","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.84.1.40","article-title":"Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients","volume":"84","author":"HR Middlekauff","year":"1991","journal-title":"Circulation"},{"issue":"2","key":"pone.0245752.ref030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1540-8167.1994.tb01157.x","article-title":"Initiating reentry: the role of nonuniform anisotropy in small circuits","volume":"5","author":"MS Spach","year":"1994","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"9","key":"pone.0245752.ref031","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1161\/01.CIR.96.9.3157","article-title":"Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat","volume":"96","author":"J Ausma","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"pone.0245752.ref032","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.1985.03350270089028","article-title":"Chronic Supraventricular Tachycardia\u2014a Curable Cause of Congestive Cardiomyopathy","volume":"253","author":"PC Gillette","year":"1985","journal-title":"Jama-J Am Med Assoc"},{"issue":"23","key":"pone.0245752.ref033","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter ablation for atrial fibrillation in congestive heart failure","volume":"351","author":"LF Hsu","year":"2004","journal-title":"New Engl J Med"},{"issue":"23","key":"pone.0245752.ref034","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1161\/01.CIR.0000132470.78896.A8","article-title":"Atrial fibrillation and ventricular dysfunction\u2014A vicious electromechanical cycle","volume":"109","author":"YM Cha","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"pone.0245752.ref035","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/01.CIR.91.5.1588","article-title":"Chronic Rapid Atrial-Pacing\u2014Structural, Functional, and Electrophysiological Characteristics of a New Model of Sustained Atrial-Fibrillation","volume":"91","author":"CA Morillo","year":"1995","journal-title":"Circulation"},{"issue":"2","key":"pone.0245752.ref036","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1378\/chest.10-3331","article-title":"Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension","volume":"141","author":"PY Sun","year":"2012","journal-title":"Chest"},{"issue":"3","key":"pone.0245752.ref037","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijcard.2012.03.071","article-title":"QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension","volume":"167","author":"JD Rich","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245752","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T06:49:40Z","timestamp":1698562180000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0245752"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Vergaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0245752","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]}}}